Average Co-Inventor Count = 7.42
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mirati Therapeutics, Inc. (14 from 38 patents)
2. Array Biopharma Inc. (4 from 329 patents)
3. Pfizer Corporation (2 from 4,455 patents)
4. Dart Neuroscience, LLC (2 from 13 patents)
18 patents:
1. 12421228 - Naphthyridine derivatives as PRC2 inhibitors
2. 12371435 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
3. 12304915 - SOS1 inhibitors
4. 12252493 - Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
5. 12006325 - Substituted furanopyrimidine compounds as PDE1 inhibitors
6. 11964989 - KRas G12D inhibitors
7. 11702418 - SOS1 inhibitors
8. 11548888 - KRas G12C inhibitors
9. 11492351 - MTA-cooperative PRMT5 inhibitors
10. 11485738 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
11. 11479551 - MTA-cooperative PRMT5 inhibitors
12. 11453683 - KRas G12D inhibitors
13. 11434247 - Substituted furanopyrimidine compounds as PDE1 inhibitors
14. 11220509 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
15. 11091495 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors